Genomic rearrangements in sporadic lymphangioleiomyomatosis: An evolving genetic story

Stephen J. Murphy, Simone B. Terra, Faye R. Harris, Aqsa Nasir, Jesse S. Voss, James Smadbeck, Sarah H. Johnson, Vishnu Serla, Jay H Ryu, Eunhee S. Yi, Benjamin R. Kipp, George Vasmatzis, Eva M Carmona Porquera

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Sporadic lymphangioleiomyomatosis is a progressive pulmonary cystic disease resulting from the infiltration of smooth muscle-like lymphangioleiomyomatosis cells into the lung. The migratory/metastasizing properties of the lymphangioleiomyomatosis cell together with the presence of somatic mutations, primarily in the tuberous sclerosis complex gene (TSC2), lead many to consider this a low-grade malignancy. As malignant tumors characteristically accumulate somatic structural variations, which have not been well studied in sporadic lymphangioleiomyomatosis, we utilized mate pair sequencing to define structural variations within laser capture microdissected enriched lymphangioleiomyomatosis cell populations from five sporadic lymphangioleiomyomatosis patients. Lymphangioleiomyomatosis cells were confirmed in each tissue by hematoxylin eosin stain review and by HMB-45 immunohistochemistry in four cases. A mutation panel demonstrated characteristic TSC2 driver mutations in three cases. Genomic profiles demonstrated normal diploid coverage across all chromosomes, with no aneuploidy or detectable gains/losses of whole chromosomal arms typical of neoplastic diseases. However, somatic rearrangements and smaller deletions were validated in the two cases which lacked TSC2 driver mutations. Most significantly, one of these sporadic lymphangioleiomyomatosis cases contained two different size deletions encompassing the entire TSC1 locus. The detection of a homozygous deletion of TSC1 driving a predicted case of sporadic lymphangioleiomyomatosis, consistent with the common two-hit TSC2 mutation model, has never been reported for sporadic lymphangioleiomyomatosis. However, while no evidence of the hereditary tuberous sclerosis complex disease was reported for this patient, the potential for mosaicism and sub-clinical phenotype cannot be ruled out. Nevertheless, this study demonstrates that somatic structural rearrangements are present in lymphangioleiomyomatosis disease and provides a novel method of genomic characterization of sporadic lymphangioleiomyomatosis cells, aiding in defining cases with no detected mutations by conventional methodologies. These structural rearrangements could represent additional pathogenic mechanisms in sporadic lymphangioleiomyomatosis disease, potentially affecting response to therapy and adding to the complex genetic story of this rare disease.

Original languageEnglish (US)
Pages (from-to)1223-1233
Number of pages11
JournalModern Pathology
Volume30
Issue number9
DOIs
StatePublished - Sep 1 2017

Fingerprint

Lymphangioleiomyomatosis
Mutation
Tuberous Sclerosis
Mosaicism
Aneuploidy
Hematoxylin
Eosine Yellowish-(YS)
Rare Diseases
Diploidy

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Genomic rearrangements in sporadic lymphangioleiomyomatosis : An evolving genetic story. / Murphy, Stephen J.; Terra, Simone B.; Harris, Faye R.; Nasir, Aqsa; Voss, Jesse S.; Smadbeck, James; Johnson, Sarah H.; Serla, Vishnu; Ryu, Jay H; Yi, Eunhee S.; Kipp, Benjamin R.; Vasmatzis, George; Carmona Porquera, Eva M.

In: Modern Pathology, Vol. 30, No. 9, 01.09.2017, p. 1223-1233.

Research output: Contribution to journalArticle

Murphy, SJ, Terra, SB, Harris, FR, Nasir, A, Voss, JS, Smadbeck, J, Johnson, SH, Serla, V, Ryu, JH, Yi, ES, Kipp, BR, Vasmatzis, G & Carmona Porquera, EM 2017, 'Genomic rearrangements in sporadic lymphangioleiomyomatosis: An evolving genetic story', Modern Pathology, vol. 30, no. 9, pp. 1223-1233. https://doi.org/10.1038/modpathol.2017.52
Murphy, Stephen J. ; Terra, Simone B. ; Harris, Faye R. ; Nasir, Aqsa ; Voss, Jesse S. ; Smadbeck, James ; Johnson, Sarah H. ; Serla, Vishnu ; Ryu, Jay H ; Yi, Eunhee S. ; Kipp, Benjamin R. ; Vasmatzis, George ; Carmona Porquera, Eva M. / Genomic rearrangements in sporadic lymphangioleiomyomatosis : An evolving genetic story. In: Modern Pathology. 2017 ; Vol. 30, No. 9. pp. 1223-1233.
@article{f7b82dea3028494d849396100447179b,
title = "Genomic rearrangements in sporadic lymphangioleiomyomatosis: An evolving genetic story",
abstract = "Sporadic lymphangioleiomyomatosis is a progressive pulmonary cystic disease resulting from the infiltration of smooth muscle-like lymphangioleiomyomatosis cells into the lung. The migratory/metastasizing properties of the lymphangioleiomyomatosis cell together with the presence of somatic mutations, primarily in the tuberous sclerosis complex gene (TSC2), lead many to consider this a low-grade malignancy. As malignant tumors characteristically accumulate somatic structural variations, which have not been well studied in sporadic lymphangioleiomyomatosis, we utilized mate pair sequencing to define structural variations within laser capture microdissected enriched lymphangioleiomyomatosis cell populations from five sporadic lymphangioleiomyomatosis patients. Lymphangioleiomyomatosis cells were confirmed in each tissue by hematoxylin eosin stain review and by HMB-45 immunohistochemistry in four cases. A mutation panel demonstrated characteristic TSC2 driver mutations in three cases. Genomic profiles demonstrated normal diploid coverage across all chromosomes, with no aneuploidy or detectable gains/losses of whole chromosomal arms typical of neoplastic diseases. However, somatic rearrangements and smaller deletions were validated in the two cases which lacked TSC2 driver mutations. Most significantly, one of these sporadic lymphangioleiomyomatosis cases contained two different size deletions encompassing the entire TSC1 locus. The detection of a homozygous deletion of TSC1 driving a predicted case of sporadic lymphangioleiomyomatosis, consistent with the common two-hit TSC2 mutation model, has never been reported for sporadic lymphangioleiomyomatosis. However, while no evidence of the hereditary tuberous sclerosis complex disease was reported for this patient, the potential for mosaicism and sub-clinical phenotype cannot be ruled out. Nevertheless, this study demonstrates that somatic structural rearrangements are present in lymphangioleiomyomatosis disease and provides a novel method of genomic characterization of sporadic lymphangioleiomyomatosis cells, aiding in defining cases with no detected mutations by conventional methodologies. These structural rearrangements could represent additional pathogenic mechanisms in sporadic lymphangioleiomyomatosis disease, potentially affecting response to therapy and adding to the complex genetic story of this rare disease.",
author = "Murphy, {Stephen J.} and Terra, {Simone B.} and Harris, {Faye R.} and Aqsa Nasir and Voss, {Jesse S.} and James Smadbeck and Johnson, {Sarah H.} and Vishnu Serla and Ryu, {Jay H} and Yi, {Eunhee S.} and Kipp, {Benjamin R.} and George Vasmatzis and {Carmona Porquera}, {Eva M}",
year = "2017",
month = "9",
day = "1",
doi = "10.1038/modpathol.2017.52",
language = "English (US)",
volume = "30",
pages = "1223--1233",
journal = "Modern Pathology",
issn = "0893-3952",
publisher = "Nature Publishing Group",
number = "9",

}

TY - JOUR

T1 - Genomic rearrangements in sporadic lymphangioleiomyomatosis

T2 - An evolving genetic story

AU - Murphy, Stephen J.

AU - Terra, Simone B.

AU - Harris, Faye R.

AU - Nasir, Aqsa

AU - Voss, Jesse S.

AU - Smadbeck, James

AU - Johnson, Sarah H.

AU - Serla, Vishnu

AU - Ryu, Jay H

AU - Yi, Eunhee S.

AU - Kipp, Benjamin R.

AU - Vasmatzis, George

AU - Carmona Porquera, Eva M

PY - 2017/9/1

Y1 - 2017/9/1

N2 - Sporadic lymphangioleiomyomatosis is a progressive pulmonary cystic disease resulting from the infiltration of smooth muscle-like lymphangioleiomyomatosis cells into the lung. The migratory/metastasizing properties of the lymphangioleiomyomatosis cell together with the presence of somatic mutations, primarily in the tuberous sclerosis complex gene (TSC2), lead many to consider this a low-grade malignancy. As malignant tumors characteristically accumulate somatic structural variations, which have not been well studied in sporadic lymphangioleiomyomatosis, we utilized mate pair sequencing to define structural variations within laser capture microdissected enriched lymphangioleiomyomatosis cell populations from five sporadic lymphangioleiomyomatosis patients. Lymphangioleiomyomatosis cells were confirmed in each tissue by hematoxylin eosin stain review and by HMB-45 immunohistochemistry in four cases. A mutation panel demonstrated characteristic TSC2 driver mutations in three cases. Genomic profiles demonstrated normal diploid coverage across all chromosomes, with no aneuploidy or detectable gains/losses of whole chromosomal arms typical of neoplastic diseases. However, somatic rearrangements and smaller deletions were validated in the two cases which lacked TSC2 driver mutations. Most significantly, one of these sporadic lymphangioleiomyomatosis cases contained two different size deletions encompassing the entire TSC1 locus. The detection of a homozygous deletion of TSC1 driving a predicted case of sporadic lymphangioleiomyomatosis, consistent with the common two-hit TSC2 mutation model, has never been reported for sporadic lymphangioleiomyomatosis. However, while no evidence of the hereditary tuberous sclerosis complex disease was reported for this patient, the potential for mosaicism and sub-clinical phenotype cannot be ruled out. Nevertheless, this study demonstrates that somatic structural rearrangements are present in lymphangioleiomyomatosis disease and provides a novel method of genomic characterization of sporadic lymphangioleiomyomatosis cells, aiding in defining cases with no detected mutations by conventional methodologies. These structural rearrangements could represent additional pathogenic mechanisms in sporadic lymphangioleiomyomatosis disease, potentially affecting response to therapy and adding to the complex genetic story of this rare disease.

AB - Sporadic lymphangioleiomyomatosis is a progressive pulmonary cystic disease resulting from the infiltration of smooth muscle-like lymphangioleiomyomatosis cells into the lung. The migratory/metastasizing properties of the lymphangioleiomyomatosis cell together with the presence of somatic mutations, primarily in the tuberous sclerosis complex gene (TSC2), lead many to consider this a low-grade malignancy. As malignant tumors characteristically accumulate somatic structural variations, which have not been well studied in sporadic lymphangioleiomyomatosis, we utilized mate pair sequencing to define structural variations within laser capture microdissected enriched lymphangioleiomyomatosis cell populations from five sporadic lymphangioleiomyomatosis patients. Lymphangioleiomyomatosis cells were confirmed in each tissue by hematoxylin eosin stain review and by HMB-45 immunohistochemistry in four cases. A mutation panel demonstrated characteristic TSC2 driver mutations in three cases. Genomic profiles demonstrated normal diploid coverage across all chromosomes, with no aneuploidy or detectable gains/losses of whole chromosomal arms typical of neoplastic diseases. However, somatic rearrangements and smaller deletions were validated in the two cases which lacked TSC2 driver mutations. Most significantly, one of these sporadic lymphangioleiomyomatosis cases contained two different size deletions encompassing the entire TSC1 locus. The detection of a homozygous deletion of TSC1 driving a predicted case of sporadic lymphangioleiomyomatosis, consistent with the common two-hit TSC2 mutation model, has never been reported for sporadic lymphangioleiomyomatosis. However, while no evidence of the hereditary tuberous sclerosis complex disease was reported for this patient, the potential for mosaicism and sub-clinical phenotype cannot be ruled out. Nevertheless, this study demonstrates that somatic structural rearrangements are present in lymphangioleiomyomatosis disease and provides a novel method of genomic characterization of sporadic lymphangioleiomyomatosis cells, aiding in defining cases with no detected mutations by conventional methodologies. These structural rearrangements could represent additional pathogenic mechanisms in sporadic lymphangioleiomyomatosis disease, potentially affecting response to therapy and adding to the complex genetic story of this rare disease.

UR - http://www.scopus.com/inward/record.url?scp=85028716765&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85028716765&partnerID=8YFLogxK

U2 - 10.1038/modpathol.2017.52

DO - 10.1038/modpathol.2017.52

M3 - Article

C2 - 28643793

AN - SCOPUS:85028716765

VL - 30

SP - 1223

EP - 1233

JO - Modern Pathology

JF - Modern Pathology

SN - 0893-3952

IS - 9

ER -